Skip to content
healthcare.dev
Get a free key

Neostigmine Methylsulfate

NDC 65219-811, Neostigmine Methylsulfate, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-811
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203629
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
65219-811-106521908111010 VIAL, MULTI-DOSE in 1 TRAY (65219-811-10) / 10 mL in 1 VIAL, MULTI-DOSE (65219-811-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/088f96eb-20b8-48f8-ac83-329f75a44ce1

Use it

Look up 65219-811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.